Shalby Limited

Shalby Limited (SHALBY) is a micro-cap Healthcare company valued at ₹1,390 crore operating in Hospital on the NSE and BSE.

Recent price move

Shalby Limited last traded at ₹129, modestly down 1.83% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarter results, showing revenue of ₹331 crore and net profit of ₹10 crore, up 11.9% and 31.2% respectively compared to the same quarter a year earlier. Promoter holding remained at 74.33%, while foreign institutional holding increased by 0.10 percentage points to 4.46%.

Financial performance

The company's business improved significantly, with annual net profit rising 1634.5% to ₹35 crore, driven by a sharp increase in the net profit margin to 3.0% from 0.2%. However, profit growth slowed in the latest quarter, with net profit rising 31.2% to ₹10 crore, while revenue grew 11.9% to ₹331 crore, showing the business is still expanding but profit growth is moderating.

Valuation multiples

The stock trades at 39.9 times earnings, a premium to the Healthcare median of 32.0, 1.57 times book value. It yields 0.8%.

Things to watch

The company's profit growth has slowed significantly over the past five years, with a -3.8% CAGR, and the latest quarter's profit growth was much lower than the annual rate. The stock is 51.1% below its 52-week high, and the return on equity remains low at 3.7%, indicating limited profitability relative to equity.

Where it stands

Shalby Limited's business has shown strong annual profit growth, but recent quarterly results suggest a slowdown in profit expansion. The stock is significantly below its 52-week high, and the company's return on equity remains low. The most recent figure is the latest quarter net profit of ₹10 crore.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.